Cargando…
Cancer Diagnostics: A Novel Blood‐Based Colorectal Cancer Diagnostic Technology Using Electrical Detection of Colon Cancer Secreted Protein‐2 (Adv. Sci. 11/2019)
In article number 1802115, Kwan Hyi Lee, Seung‐Jae Myung, and co‐workers successfully develop an electric field effect colorectal sensor (E‐FECS) equipped with a thin film transistor‐chipset, a disposable multiwell gate, and an integrated measurement box to detect colon cancer secreted protein‐2 (CC...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548943/ http://dx.doi.org/10.1002/advs.201970063 |
Sumario: | In article number 1802115, Kwan Hyi Lee, Seung‐Jae Myung, and co‐workers successfully develop an electric field effect colorectal sensor (E‐FECS) equipped with a thin film transistor‐chipset, a disposable multiwell gate, and an integrated measurement box to detect colon cancer secreted protein‐2 (CCSP‐2) in blood samples from human colorectal cancer (CRC) patients. The E‐FECS system has the potential as a diagnostic tool for postoperative monitoring and early detection of CRC. [Image: see text] |
---|